Slowing progression in Alzheimer's disease: potential of `Cerebrolysin'

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1265, 2000-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safely slowing down the decline in Alzheimer’s disease: gene therapy shows potential

By Braddock Martin

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 913-915

Informa Healthcare

Access to resources Recommend Favorite

Slowing the Progression of Adult Chronic Kidney Disease: Therapeutic Advances

By Maarten W. Taal

Drugs, Vol. 64, Iss. 20, 2004-01 ,pp. : 2273-2289

Adis International

Access to resources Recommend Favorite

Therapeutic Potential in Alzheimer Disease

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1605-1610

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of FPF 1070 (Cerebrolysin) in Patients with Alzheimer's Disease: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

By Shifu X. Heqin Y. Peifen Y.

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite

Antigonadotropins: A Novel Strategy to Halt Alzheimer's Disease Progression

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 685-690

Bentham Science Publishers

Access to resources Recommend Favorite